ALS (motor neurone disease) trials in Belgium

In Belgium 14 Also abroad 226

14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Taking people
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Where
Leuven
Age
18 years and over
People
36 worldwide
Run by
Vector Y Therapeutics
See details and how to joinNCT07287397 · EU 2025-522697-37-00
Phase 1Taking people
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Where
Leuven
Age
18 years to 75 years
People
36 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07100119 · EU 2025-521295-60-00
Phase 3Taking people
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Where
Leuven
Age
18 years to 80 years
People
500 worldwide
Run by
Prilenia
See details and how to joinNCT07322003
Phase 1Taking people
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Where
Leuven
Age
18 years to 80 years
People
32 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07571174
Phase 1Taking people
A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Where
Leuven
Age
18 years to 80 years
People
32 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07571200 · EU 2026-525574-19-00
Phase 1/2Taking people
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
Where
Leuven
Age
18 years and over
People
54 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06351592 · EU 2023-510344-20-00
Phase 2Taking people
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Where
Leuven
Age
18 years and over
People
240 worldwide
Run by
Zydus Therapeutics Inc.
See details and how to joinNCT07023835 · EU 2025-522580-15-00
No phaseEnrolling by invitation
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
Where
Leuven
Age
28 days and over
People
1,600
Run by
prof. dr. Koen Van Laere
See details and how to joinNCT07595666
Phase 3Taking people
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
Where
Leuven
Age
18 years and over
People
420 worldwide
Run by
Ferrer Internacional S.A.
See details and how to join2025-524002-16-00 · EU 2025-524002-16-00
No phaseTaking people
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
Where
Leuven
Age
18 years to 90 years
People
300
Run by
Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07509125
Phase 1Taking people
Quantification of Hsp90 in the Human Brain
Where
Leuven
Age
18 years to 70 years
People
48
Run by
Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07380204 · EU 2023-510532-36-00
No phaseTaking people
Continuous Measurement of Activity in Patients With Muscle Pathology and in Control Subjects. ActiSLA Part.
Where
Liège
Age
18 years and over
People
45
Run by
Centre Hospitalier Universitaire de Liege
See details and how to joinNCT04882904
Phase 3Taking people
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Where
Leuven
Age
18 years to 81 years
People
495 worldwide
Run by
AB Science
See details and how to joinNCT03127267
No phaseTaking people
Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.
Where
Leuven, Liège
Age
18 years and over
People
30 worldwide
Run by
Centre Hospitalier Universitaire de Liege
See details and how to joinNCT06228001